Lorenzo De Angelis

Lorenzo De Angelis

Auto-generated profile, based on publicly available information

Lorenzo De Angelis

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Molecular Metabolism
Verified
Journal Article
Open access
BKBen Arpad Kappel
Ben Arpad Kappel
LALorenzo De Angelis
Lorenzo De Angelis
MHMichael Heiser
Michael Heiser
MBMarta Ballanti
Marta Ballanti
RSRobert Stoehr
Robert Stoehr
MFMassimo Federici
Massimo Federici
The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term usage has been identified as an independent risk factor for atherosclerosis-driven events. The aim of this study was to explore the interaction between gut dysbiosis by antibiotics and metabolic pathways with the impact on atherosclerosis development. We combined oral antibiotics with different diets in an Apolipoprotein E-knockout mouse model linking gut microbiota to atherosclerotic lesion development via an integrative cross-omics approach including serum metabolomics and cecal 16S rRNA targeted metagenomic sequencing. We further investigated patients with carotid atherosclerosis compared to control subjects with comparable cardiovascular risk. Here, we show that increased atherosclerosis by antibiotics was connected to a loss of intestinal diversity and alterations of microbial metabolic functional capacity with a major impact on the host serum metabolome. Pathways that were modulated by antibiotics and connected to atherosclerosis included diminished tryptophan and disturbed lipid metabolism. These pathways were related to the reduction of certain members of Bacteroidetes and Clostridia by antibiotics in the gut. Patients with atherosclerosis presented a similar metabolic signature as those induced by antibiotics in our mouse model. Taken together, this work provides insights into the complex interaction between intestinal microbiota and host metabolism. Our data highlight that detrimental effects of antibiotics on the gut flora are connected to a pro-atherogenic metabolic phenotype beyond classical risk factors.

1 June 2016 in Atherosclerosis
Verified
Journal Article
Closed access
BKBen Arpad Kappel
Ben Arpad Kappel
RSRobert Stöhr
Robert Stöhr
LALorenzo De Angelis
Lorenzo De Angelis
MMMaria Mavilio
Maria Mavilio
RMRossella Menghini
Rossella Menghini
MFMassimo Federici
Massimo Federici